Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that company
management will discuss Cubist’s business activities and financial
outlook at the Oppenheimer 23rd Annual Healthcare Conference
in December 2012. Details are below.
Steve Gilman, EVP and Chief Scientific Officer
Oppenheimer 23rd Annual Healthcare Conference
Thursday, December 13, 2012
10:35 a.m. Eastern Time
The Waldorf Astoria, New York City
Live audio with slide webcast can be accessed here.
Cubist Pharmaceuticals, Inc. is a biopharmaceutical company focused on
the research, development, and commercialization of pharmaceutical
products that address significant unmet medical needs in the acute care
environment. Cubist is headquartered in Lexington, Mass. Additional
information can be found at Cubist’s website.
Investors: Cubist Pharmaceuticals, Inc. Eileen
C. McIntyre, 781-860-8533 Senior Director, Investor Relations firstname.lastname@example.org or Media: Cubist
Pharmaceuticals, Inc. Julie DiCarlo, 781-860-8063 Senior
Director, Corporate Communications email@example.com